Latest Breaking News On - Travere therapeutics - Page 2 : comparemela.com

Brokerages Set Travere Therapeutics, Inc. (NASDAQ:TVTX) Target Price at $16.69

Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the thirteen research firms that are presently covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12-month price objective […]

Dynamic technology lab private ltdNisa investment advisorsTravere therapeutics company profileCanaccord genuity groupChina universal asset management coEntrypoint capitalWells fargo companyTravere therapeutics incTravere therapeuticsGet free reportGenuity groupWells fargoTherapeutics trading downPoint capitalInvestment advisorsUniversal asset management

GW&K Investment Management LLC Lowers Stock Holdings in Travere Therapeutics, Inc. (NASDAQ:TVTX)

GW&K Investment Management LLC decreased its position in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 5.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 318,266 shares of the company’s stock after selling 19,348 shares during the quarter. GW&K Investment Management […]

Schonfeld strategic advisorsVanguard group incTravere therapeutics incCanaccord genuity groupWells fargo companyVontobel holding ltdGwk investment managementTravere therapeuticsFree reportPartners managementPension plan investment boardStrategic advisorsGenuity groupGet free reportIga nephropathyTravere therapeutics daily

Russell Investments Group Ltd. Has $926,000 Stake in Travere Therapeutics, Inc. (NASDAQ:TVTX)

Russell Investments Group Ltd. increased its position in Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 5.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 103,012 shares of the company’s stock after buying an additional 5,499 shares during the period. Russell Investments Group Ltd. owned […]

United statesZurcher kantonalbank zurich cantonalbankCanaccord genuity groupTravere therapeutics incWells fargo companyNisa investment advisorsRussell investments group ltdChina universal asset management coRussell investments groupTravere therapeuticsFree reportInvestments groupInvestment advisorsUniversal asset managementKantonalbank zurich cantonalbankTeacher retirement system

Irbesartan, Sparsentan Treatment Demonstrate Significantly Slower Kidney Function Decline Compared with SoC

Irbesartan, Sparsentan Treatment Demonstrate Significantly Slower Kidney Function Decline Compared with SoC
hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.

United kingdomWu gongResearchgate wu gongUniversity of leicesterAnalysis groupOhio state universityNational kidney foundationTravere therapeuticsUnited kingdom national registryRare kidney diseases

Sparsentan Bests Irbesartan for Rare, Progressive Kidney Disease

Sparsentan Bests Irbesartan for Rare, Progressive Kidney Disease
medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkSparsentan filspariMichellen rheaultUniversity of minnesota medical school in minneapolisNational kidney foundationMinnesota medical schoolSpring clinicalKidney weekTravere therapeuticsNew york city